- Venue Boston Marriott Peabody, MA
- Dates November 16-18, 2026
- Call +1-815-595-8049
Speakers
Sanjay Gurunathan
MD- Speciality: Vaccines and Infectious Disease R&D
- Company: GSK
- Designation: Senior Vice President and Global Head
Personal Information
Sanjay Gurunathan, MD, joined GSK as Senior Vice President and Global Head, Vaccines and Infectious Disease R&D in June 2025. With 25 years of global experience in infectious disease and vaccines R&D, Dr. Gurunathan is dedicated to advancing public health through scientific innovation, strategic execution, and global collaboration. He leads large, international, multi-disciplinary teams, managing the end-to-end development of vaccines targeting high-burden infectious disease.
Dr. Gurunathan’s impressive track record includes contributing to over 20 successful global regulatory approvals, leading eight large-scale, multinational Phase III efficacy trials, and producing more than 50 scientific publications. His expertise bridges scientific rigor with strategic alignment, ensuring efficient execution of programs that meet public health needs and business objectives.
Additionally, Dr. Gurunathan has led change initiatives, built and retained high-performing global teams, and played key roles in due diligence efforts for partnerships and acquisitions. His focus remains being ambitious for patients, delivering impactful solutions in the fight against infectious disease worldwide.
Scientia Meetings
Connecting Minds for Scientific Progress!
Join us in revolutionizing conferences! Scientia Meetings is launching events across the country, offering a unique platform for scientists and researchers to share knowledge, explore innovative ideas, and foster collaborations. Buy Ticket
Clients
Our Official
Our Official
Sponsors
Our curated gatherings ensure purposeful networking, creating opportunities tailored to your needs. Let's shape the future together—where knowledge connects, opportunities arise, and science thrives!
Buy Ticket
Get The Latest Updates
Signup For Newsletter
If You Want to Update For on Our Site a#Subscribe Now.